Vertex Pharmaceuticals (VRTX) Total Debt (QoQ) (2010 - 2016)

Vertex Pharmaceuticals (VRTX) Total Debt (QoQ) (2010 - 2016) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Dec 31, 2016 -74.81%
Sep 30, 2016 0.42%
Jun 30, 2016 0.23%
Mar 31, 2016 32.14%
Dec 31, 2015 -24.07%
Sep 30, 2015 0.01%
Jun 30, 2015 0.01%
Mar 31, 2015 0.01%
Dec 31, 2014 0.01%
Mar 31, 2011 43.88%
Dec 31, 2010 202.54%
Sep 30, 2010 -72.33%